PATENT CLAIM ANALYSIS

Application Number: 16131003
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-01
Patent Classification: ["530", "350000"]

Abstract:
The invention herein disclosed is related to epitopes useful in methods of diagnosing, treating, and preventing coeliac disease. Therapeutic compositions which comprise at least one epitope are provided.

Claim (Index 69):
A method according to  claim 68  comprising:\n (d) obtaining a transgenic seed from a first-generation transgenic plant obtainable by the method according to  claim 67 , then obtaining a second-generation transgenic progeny plant from the transgenic seed; \n and/or \n (e) propagating clonally a first-generation transgenic plant obtainable by the method according to  claim 66  to give a second-generation progeny plant; \n and/or \n (f) crossing a first-generation transgenic plant obtainable by a method according to  claim 66  with another plant to give a second-generation progeny plant; \n and optionally \n (g) obtaining transgenic progeny plants of one or more further generations from the second-generation progeny plant thus obtained.

Metadata:
- Claim Count in Document: 68.0
- Percentile: 97.0
- Lexical Diversity: 1.06667
- Patent Class: 530.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['14630004', '13541864', '10516837', '10089700', '11630818']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.684231360308208
- 35 USC 102 Novelty (BERT): 0.548673008240281
- Combined Prediction Score: 0.6706755251014154
- Mean Citation Score: 413.16597999999993
- Max Citation Score: 487.38614
- Similarity Product: 234.5796591524356

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test